For example, by targeting the bromodomain, a small molecule inhibitor NVS-CECR2-1 can affect CECR2 binding to chromatin and induce apoptosis in several cancer cell lines (Pérez-Salvia and Esteller, 2017; Park et al., 2020). This evidence concerns the gene CECR2 and cancer.